Cargando…

De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017

Advances in patient care and immunosuppressive drugs have improved graft survival, resulting in an increase in kidney transplantation (KT); however, persistent immunosuppression is thought to cause late occurrence of cancer. This population-based study consisted of a total of 14,842 patients whose d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Boyeon, Kang, Minjin, Kim, Yoonjung, Lee, Hyung Soon, Kim, Banseok, Lee, Jung Jun, Park, Yongjung, Lee, Kyung-A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396914/
https://www.ncbi.nlm.nih.gov/pubmed/34441826
http://dx.doi.org/10.3390/jcm10163530
_version_ 1783744484728635392
author Kim, Boyeon
Kang, Minjin
Kim, Yoonjung
Lee, Hyung Soon
Kim, Banseok
Lee, Jung Jun
Park, Yongjung
Lee, Kyung-A
author_facet Kim, Boyeon
Kang, Minjin
Kim, Yoonjung
Lee, Hyung Soon
Kim, Banseok
Lee, Jung Jun
Park, Yongjung
Lee, Kyung-A
author_sort Kim, Boyeon
collection PubMed
description Advances in patient care and immunosuppressive drugs have improved graft survival, resulting in an increase in kidney transplantation (KT); however, persistent immunosuppression is thought to cause late occurrence of cancer. This population-based study consisted of a total of 14,842 patients whose data from the years 2002 to 2017 were collected from the National Health Information Database in South Korea. Malignancies occurred in 7.6% of the total KT patients. Prostate and thyroid cancers were the most common in males and females, respectively. From the age-adjusted incidence analysis, Kaposi’s sarcoma showed the highest standardized incidence ratio in both male and female patients. According to the linear regression model, cancer incidence in KT recipients under immunosuppressive conditions increased by approximately 0.1% each month. Patients’ age over 39 and the use of prednisolone as an initial steroid regimen were associated with increased risk of cancer development after KT. Our regression and proportional hazards models will help clinicians to predict the approximate cancer incidence risk when monitoring KT recipients. Based on the largest available national database, screening or monitoring methods for cancer detection and prevention can be established for KT patients by considering the factors involved in cancer development.
format Online
Article
Text
id pubmed-8396914
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83969142021-08-28 De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017 Kim, Boyeon Kang, Minjin Kim, Yoonjung Lee, Hyung Soon Kim, Banseok Lee, Jung Jun Park, Yongjung Lee, Kyung-A J Clin Med Article Advances in patient care and immunosuppressive drugs have improved graft survival, resulting in an increase in kidney transplantation (KT); however, persistent immunosuppression is thought to cause late occurrence of cancer. This population-based study consisted of a total of 14,842 patients whose data from the years 2002 to 2017 were collected from the National Health Information Database in South Korea. Malignancies occurred in 7.6% of the total KT patients. Prostate and thyroid cancers were the most common in males and females, respectively. From the age-adjusted incidence analysis, Kaposi’s sarcoma showed the highest standardized incidence ratio in both male and female patients. According to the linear regression model, cancer incidence in KT recipients under immunosuppressive conditions increased by approximately 0.1% each month. Patients’ age over 39 and the use of prednisolone as an initial steroid regimen were associated with increased risk of cancer development after KT. Our regression and proportional hazards models will help clinicians to predict the approximate cancer incidence risk when monitoring KT recipients. Based on the largest available national database, screening or monitoring methods for cancer detection and prevention can be established for KT patients by considering the factors involved in cancer development. MDPI 2021-08-11 /pmc/articles/PMC8396914/ /pubmed/34441826 http://dx.doi.org/10.3390/jcm10163530 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Boyeon
Kang, Minjin
Kim, Yoonjung
Lee, Hyung Soon
Kim, Banseok
Lee, Jung Jun
Park, Yongjung
Lee, Kyung-A
De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017
title De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017
title_full De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017
title_fullStr De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017
title_full_unstemmed De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017
title_short De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017
title_sort de novo cancer incidence after kidney transplantation in south korea from 2002 to 2017
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396914/
https://www.ncbi.nlm.nih.gov/pubmed/34441826
http://dx.doi.org/10.3390/jcm10163530
work_keys_str_mv AT kimboyeon denovocancerincidenceafterkidneytransplantationinsouthkoreafrom2002to2017
AT kangminjin denovocancerincidenceafterkidneytransplantationinsouthkoreafrom2002to2017
AT kimyoonjung denovocancerincidenceafterkidneytransplantationinsouthkoreafrom2002to2017
AT leehyungsoon denovocancerincidenceafterkidneytransplantationinsouthkoreafrom2002to2017
AT kimbanseok denovocancerincidenceafterkidneytransplantationinsouthkoreafrom2002to2017
AT leejungjun denovocancerincidenceafterkidneytransplantationinsouthkoreafrom2002to2017
AT parkyongjung denovocancerincidenceafterkidneytransplantationinsouthkoreafrom2002to2017
AT leekyunga denovocancerincidenceafterkidneytransplantationinsouthkoreafrom2002to2017